Hsiang‐Chi Huang
Impact in
-
- Cancer-related Molecular Pathways
-
- Galectins and Cancer Biology
Papers in
-
- Glycosylation and Glycoproteins Research 4
- RNA modifications and cancer 3
- Fibroblast Growth Factor Research 1
- Ubiquitin and proteasome pathways 1
-
- Immunotherapy and Immune Responses 1
- Co-authors
- Reiji Kannagi (6 shared papers)Ming‐Jing Hwang (2 shared papers)Ching‐Shu Suen (2 shared papers)Shing‐Jyh Chang (3 shared papers)Fu‐Tong Liu (1 shared paper)Chia-Wei Li (3 shared papers)Jung-Mao Hsu (3 shared papers)Te-An Lee (3 shared papers)
- Journals
- Cells (2 papers)Nature Communications (1 paper)Scientific Reports (1 paper)Nucleic Acids Research (1 paper)Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hsiang‐Chi Huang
12 papers receiving 155 citations
Peers
Comparison fields: 5 of 51
- Oncology 45
- Immunology 35
- Biotechnology 13
- Cancer Research 18
- Infectious Diseases 22
Countries citing papers authored by Hsiang‐Chi Huang
This map shows the geographic impact of Hsiang‐Chi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang‐Chi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang‐Chi Huang more than expected).
Fields of papers citing papers by Hsiang‐Chi Huang
This network shows the impact of papers produced by Hsiang‐Chi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang‐Chi Huang. The network helps show where Hsiang‐Chi Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hsiang‐Chi Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail. | 2021 | 24 |
| 3 | 2019 | 19 | |
| 4 | 2019 | 16 | |
| 5 | Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis. | 2021 | 14 |
| 6 | 2019 | 11 | |
| 7 | 2025 | 10 | |
| 8 | 2018 | 9 | |
| 9 | Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis. | 2022 | 9 |
| 10 | 2015 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2025 | 1 |
About Hsiang‐Chi Huang
Hsiang‐Chi Huang is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Epidemiology, having authored 12 papers that have together received 156 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (4 papers), RNA modifications and cancer (3 papers), Influenza Virus Research Studies (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Fibroblast Growth Factor Research (1 paper), Ubiquitin and proteasome pathways (1 paper), NF-κB Signaling Pathways (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Oncology (45 citations), Immunology (35 citations), Biotechnology (13 citations), Cancer Research (18 citations) and Infectious Diseases (22 citations). Hsiang‐Chi Huang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Reiji Kannagi, Ming‐Jing Hwang, Ching‐Shu Suen, Shing‐Jyh Chang, Fu‐Tong Liu, Chia-Wei Li, Jung-Mao Hsu, Te-An Lee, Yun‐Ju Lai and Wen‐Cheng Chou. Their work appears in journals such as Cells, Nature Communications, Scientific Reports, Nucleic Acids Research and Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.